Ohio State Researcher Sentenced to Prison for Secret China Ties

Rheumatologist Song Guo Zheng pleaded guilty in November to delivering US-funded research to China.

Written byLisa Winter
| 2 min read
US and Chinese flags

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK.COM, THEADESIGN

After admitting to lying on US federal grant applications about connections to Chinese research institutions, 58-year-old rheumatologist Song Guo Zheng has been sentenced to 37 months in federal prison. The United States Department of Justice (DOJ) released a statement on Friday (May 14) detailing the nature of the sentencing, along with Zheng’s admission of participation in a Chinese program tied to the theft of intellectual property from the US and other countries. He also owes a combined $4 million in restitution to the National Institute of Health and the Ohio State University (OSU) for falsifying grant applications.

Zheng has had an illustrious career in the field of rheumatology and immunology and is an authority on the regulatory T-cells that inhibit immune responses. After obtaining his MD in China and PhD in France, Zheng came to the US to complete postdoctoral studies at the University of California, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Lisa joined The Scientist in 2017. As social media editor, some of her duties include creating content, managing interactions, and developing strategies for the brand’s social media presence. She also contributes to the News & Opinion section of the website. Lisa holds a degree in Biological Sciences with a concentration in genetics, cell, and developmental biology from Arizona State University and has worked in science communication since 2012.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies